Further studies on the antiviral activity of alloferon and its analogues

Journal of Peptide Science

Volumn 17, Issue 11, 2011, Pages 715-719

  Kuczer, Mariola ^a   Midak Siewirska, Anna ^b   Zahorska, Renata ^b   Łuczak, Mirosław ^b   Konopińska, Danuta ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Alloferon; Antiviral activity; Coxsackie B2 virus; Human Herpes Virus; Insect peptides

Indexed keywords

ALLOFERON; ALLOFERON DERIVATIVE; ANTIVIRUS AGENT; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CIRCULAR DICHROISM; COXSACKIE VIRUS; CYTOTOXICITY; DNA VIRUS; DRUG SYNTHESIS; HERPES VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; RNA VIRUS; VIRUS INHIBITION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CIRCULAR DICHROISM; DNA VIRUSES; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDES; RNA VIRUSES;

COXSACKIEVIRUS; HERPESVIRIDAE; HEXAPODA; RNA VIRUSES; SIMPLEXVIRUS;

EID: 80054995336     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1388     Document Type: Article

References (25)

1. Chernysh S, Kim SI, Bekker G, Pleskach VA, Filatova NA, Anikin VB, Platonov VG, Bulet P. Antiviral and antitumor peptides from insects. PNAS 2002; 99: 12628-12632.
2. Ryu MJ, Anikin V, Hong SH, Jeon H, Yu YG, Yu MH, Chernysh S, Lee C. Activation of NF-kappaB by alloferon through down-regulation of antioxidant proteins and IkappaBalpha. Mol. Cell. Biochem. 2008; 313: 91-102.
3. Kuczer M, Dziubasik K, Midak-Siewirska A, Zahorska R, Łuczak M, Konopińska D. Studies of insect peptides alloferon, Any-GS and their analogues. Synthesis and antiherpes activity. J. Pept. Sci. 2010; 16: 186-192.
4. Jassim SAA, Naji MA. Novel antiviral agents: a medicinal plant perspective. J. Appl. Microbiol. 2003; 95: 412-427.
5. Abonyi DO, Adikwu MU, Esimone CO, Ibezim EC. Plants as sources of antiviral agents. Afr. J. Biotechnol. 2009; 8: 3989-3994.
6. Carriel-Gomes MC, Kratz JM, Barracco MA, Bachére E, Barardi CR, Simões CM. In vitro antiviral activity of antimicrobial peptides against herpes simplex virus 1, adenovirus, and rotavirus. Mem. Inst. Oswaldo. Cruz. 2007; 102: 469-472.
7. Mohan KV, Rao SS, Atreya CD. Antiviral activity of selected antimicrobial peptides against vaccinia virus. Antiviral Res. 2010; 86: 306-311.
8. Krawczyk E, Łuczak M. Antiviral activity of natural compounds and their derivatives. Post. Mikrobiol. 2005; 44: 239-252.
9. González-Chávez SA, Arévalo-Gallegos S, Rascón-Cruz Q. Lactoferrin: structure, function and applications. Int. J. Antimicrob. Agents 2009; 33: 301.e1-301.e8.
10. Dalla Bona A, Formaggio F, Peggion C, Kaptein B, Broxterman Qb, Galdiero S, Galdiero M, Vitiello Mt, Benedetti E, Toniolo C. Synthesis, conformation, and bioactivity of novel analogues of the antiviral lipopeptide halovir. A. J. Pept. Sci. 2006; 12: 748-757.
11. Ye XY, Ng TB. Purification of angularin, a novel antifungal peptide from adzuki beans. J. Peptide Sci. 2002; 8: 101-106.
12. Słocińska M, Marciniak P, Rosiński G. Insects antiviral and anticancer peptides: new leads for the future? Protein Pept. Lett. 2008; 15: 578-585.
13. Albiol Matanic VC, Castilla V. Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Int. J. Antimicrob. Agents 2004; 23: 382-389.
14. Kowalik-Jankowska T, Biega ł, Kuczer M, Konopińska D. Mononuclear copper(II) complexes of alloferons 1 and 2:A combined potentiometric and spectroscopic studies. J. Inorg. Biochem. 2009; 103: 135-142.
15. Docherty JJ, Pollock JJ. Inactivation of herpes simplex virus types 1 and 2 by synthetic histidine peptides. Antimicrob. Agents Chemother. 1987; 31: 1562-1566.
16. Reed LJ, Muench HA. A simple method of estimating fifty per cent endpoint. Am. J. Hyg. 1938; 27: 493-497.
17. Woody RW. Circular dichroism of peptides. In Peptides. Hruby VJ (ed). Academic Press: Orlando, 1985; 15-114.
18. Schang LM. Herpes simplex viruses in antiviral drug discovery. Curr. Pharm. Des. 2006; 12: 1357-1370.
19. Snoeck R. Antiviral therapy of herpes simplex. Int. J. Antimicrob. Agents. 2000; 16: 157-159.
20. Brown TJ, McCrary M, Tyring SK. Antiviral agents: nonantiviral drugs. J. Am. Acad. Dermatol. 2002; 47: 581-99.
21. Chen TC, Weng KF, Chang SC, Lin JY, Huang PN, Shih SR. Development of antiviral agents for enteroviruses. J. Antimicrob. Chemother. 2008; 62: 1169-117.
22. Barnard DL. Current status of anti-picornavirus therapies. Curr. Pharm. Des. 2006; 12: 1379-1390.
23. De Palma AM, Vliegen I, De Clercq E, Neyts J. Selective inhibitors of picornavirus replication. Med. Res. Rev. 2008; 28: 823-884.
24. Gaby AR. Natural remedies for herpes simplex. Altern. Med. Rev. 2006; 11: 93-101.
25. Sitohy M, Billaudel S, Haertlé T, Chobert JM. Antiviral activity of esterified α-lactalbumin and β-lactoglobulin against herpes simplex virus type 1. Comparison with the effect of acyclovir and L-polylysines. J. Agric. Food Chem. 2007; 55: 10214-10220.